| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 140,799 | 140,263 | 141,833 | 151,726 | | Cost of Revenue | 85,418 | 84,102 | 83,141 | 91,732 | | | Gross Profit | 55,381 | 56,161 | 58,692 | 59,994 | | | Operating Expenses | | Research Development | 16,705 | 16,657 | 16,780 | 16,907 | | Selling General and Administrative | 30,176 | 31,825 | 32,826 | 30,656 | | Non Recurring | 601 | 1,067 | 962 | 820 | | Others |
-
|
-
|
-
| 441 | | | | Total Operating Expenses |
-
|
-
|
-
| 48,824 | | | | Operating Income or Loss | 7,899 | 6,612 | 8,124 | 11,170 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,916) | (306) | 1,592 | 717 | | Earnings Before Interest And Taxes | 3,983 | 6,306 | 9,716 | 11,887 | | Interest Expense | (3,107) | 1,195 | 1,912 | 1,736 | | Income Before Tax | 7,090 | 5,111 | 7,804 | 10,151 | | Income Tax Expense | 1,030 | 1,451 | 1,466 | 2,802 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,060 | 3,660 | 6,338 | 7,349 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,060 | 3,660 | 6,338 | 7,349 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,060 | $3,660 | $6,338 | $7,349 |
|
0.11% Nasdaq 
Income Statement
